Fluoropyrimidine-associated gastrointestinal toxicity: pharmacovigilance reporting signals and in vitro evidence of epithelial injury, barrier impairment, and inflammatory responses
Experimental evidence is provided that fluoropyrimidine exposure is associated with epithelial injury, impaired barrier function, and epithelial inflammatory responses, and the reporting signals do not estimate event frequency in treated populations or establish causality.